final - phys/chemical injuries Flashcards
extremely common “white line” located on the buccal mucosa at the level of the OP - usually bilateral
frictional irritation/trauma from teeth - passive keratosis
linea alba
ragged superficial keratosis (active keratosis)
anterior buccal mucosa - symmetrically distributed above and below the OP
no ulceration
morsicatio buccarum - cheek chewing
~biopsy may be indicated to r/o oral hairy leukoplakia
morsicatio linguarum - tongue
morsicatio labiorum - labial mucosa
removable yellowish-white fibrinopurulent membrane - surrounded by variable erythema and hyperkeratotic border
common lesion - any age group
buccal and labial mucosa, and tongue are most common sites
traumatic ulcer
sometimes fibrosis is so bad - ulcer won’t heal until we excise and achieve primary closure
traumatic ulcer tx
eliminate source of trauma (broken cuso, overhang etc)
may protect the area of ulceration - Zilactin, Orabase (Doesn’t accelerate healing phases but does make it less tender )
if lesion doesn’t resolve - biopsy indicated
Coagulation necrosis of the epi on palatal mucosa and anterior tongue
subepi vesicle/bulla formation if severe
generally heal relatively quickly
thermal injury
white coagulation necrosis of the epi - heals rapidly once offending agent removed
chemical injury
aspirin, h202, phenol most common
Chemotherapy-related epi necrosis
variety of mechanisms by which these drugs interfere with cellular metabolism, why oral? primarily affected
rapidly dividing cells
may begin within 1st few days of chemo
resolves 2-3 weeks after cessation of chem
secondary to ionizing radiation used to tx malignancies in the head/neck region
involves tissue within field of radiation
damage to rapidly dividing basal cells
resolves 2-3 weeks after therapy ends
radiation mucositis
Anything tissue in the field of radtion
Usually only get this if head and neck
Short lived process
Medication-related osteonecrosis of the jaws - MRONJ aka ARONJ,BRONJ,BON
first identified with _ 2003
now other antiresorptive and antigiogenic agents associated with osteonecrosis
bisphosphonates
bind to bone and inhibit it’s degradation (resportion) - but inhibiting osteoclast fxn
used for osteoporosis and pathologic bone resportion (pagets and malgnancies )
bisphosphonates bin to bone and inhibit osteoclastic activity - decreasing bone turnover
1/2 life in bone is approx _
~10 years
skeletal effects for over 4 decades - “frozen skeleton”
a newer type of anti-resorptive is also associated with ONJ
monoclonal Ab
denosumab
very recently - other drugs without effects on osteoclasts have been assocaited with ONJ - antiangiogenic agents like _ and _
avastin
sunitinib
Dx of MRONJ
-current or previous tx with a bisphosphonate or or agent
- exposed bone in the maxillofacial region persisting for more than _
- no history of _
8 weeks - non healing exposed bone for 8 weeks
no hx of radiation therapy to the jaws
BRONJ
89% associated with _ therapy - mainly zoledronate and pamidronate
intravenous bisphos therapy
11% with oral therapy - txing osteoporosis main alendronate
mandible:maxilla = 2:1
Mandible more common than maxilla
More bone in mandi, less vascular
Primarily occurs in the jaws - rarely any where else This is due to rate of turnover in the jaw is so fast compared to other bone
BRONJ
67% of cases preceded by _ procedure
in cancer pt’s with BP’s - overall prevalence of ONJ is ~5%, prevalence in osteoporosis patients tx with BPs is 100x’s more/less? frequent
67% tooth extraction
7% - other dental factors
26% - no predisposing factor
100x less frequent osteoporosis